A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care
NCT05488444 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2024-10-22
Summary
Project Lets start will provide individual support to breast cancer patients with the goal of reducing delay to chemotherapy initiation. In this study participants will identify areas of need and work with patient navigators who will provide weekly 1-1 support throughout patient's journey to beginning chemotherapy
Conditions
Interventions
- BEHAVIORAL
-
Navigator Phone Calls
The patient navigator will call you every week as described above in "Study Groups." These phone calls will continue until you begin receiving chemotherapy.
- BEHAVIORAL
-
Exit Interview
Participants will be asked to complete an exit interview either in person or by phone
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Mariana Chavez Mac Gregor, MD · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-25
- Primary Completion
- 2023-10-17
- Completion
- 2023-10-17
Countries
- United States
Study Locations
More Related Trials
-
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
NCT00724386 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00072319 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer
NCT05841381 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
NCT00427427 ·Status: TERMINATED ·Phase: PHASE2
-
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer
NCT04087057 ·Status: COMPLETED
-
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
NCT00310089 ·Status: COMPLETED ·Phase: NA
-
Reirradiation With Concurrent Paclitaxel for Breast Cancer
NCT02058667 ·Status: WITHDRAWN ·Phase: PHASE1
-
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
NCT03628066 ·Status: COMPLETED ·Phase: PHASE2
-
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT04297384 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
NCT00014222 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer
NCT00206453 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
NCT00038402 ·Status: COMPLETED ·Phase: PHASE3
-
Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer
NCT00001493 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
NCT05634954 ·Status: WITHDRAWN ·Phase: PHASE1
-
'ADVANCE' (A Pilot Trial)
NCT03858322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
NCT03423849 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204 ·Status: TERMINATED ·Phase: PHASE2
-
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
NCT06405828 ·Status: RECRUITING ·Phase: NA
-
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
NCT00721409 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors
NCT01628887 ·Status: TERMINATED ·Phase: NA
-
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
NCT02999477 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
NCT00617370 ·Status: COMPLETED ·Phase: NA
-
Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer
NCT01277757 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
NCT00050167 ·Status: COMPLETED ·Phase: PHASE1